MacLuskyI, McLaughlinFJ, LevisonH.Cystic fibrosis: Part I. Curr Probl Pediatr1985;XV:1–49.
2.
AndersenDH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. AJDC1938;56:344–399.
3.
KnowlesMR, StuttsMJ, YankaskasJR, GatzyJT, BoucherRC. Abnormal respiratory epithelial ion transport in cystic fibrosis. Clin Chest Med1986;7:285–297.
4.
KlingerKW. Genetics of cystic fibrosis. Semin Respir Med1985;6: 243–251.
5.
RiordanJR, RommensJM, KeremB-S, AlonN, RozmahelR, GrzelczakZ, . Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science1989;245:1066–1073.
6.
KeremB-S, RommensJM, BuchananJA, MarkiewiczD, CoxTK, ChakravartiA, . Identification of the cystic fibrosis gene: Genetic analysis. Science1989;345:1073–1080.
7.
TsuiL-C. International cystic fibrosis genetics consortium update, May 1991. Bethesda MD: Cystic Fibrosis Foundation.
8.
LemnaWK, FeldmanGL, KeremB-S, FernbachSD, ZevkovichEP, O'BrienWE, . Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med1990;322:291–296.
9.
ParkRW, GrandRJ. Gastrointestinal manifestations of cystic fibrosis: A review. Gastroenterol1981;81:1143–1161.
10.
HolsclawD, EcksteinH, NixonH.Meconium ileus: A 20 year review of 109 cases. AJDC1965;109:101–113.
11.
SternRC, IzantRJJr, BoatTF, WoodRE, MatthewsLW, DoershukCF. Treatment and prognosis of rectal prolapse in cystic fibrosis. Gastroenterol1982;82:707–710.
12.
HolsclawD, RocmansC, ShwachmanH.Intussesception in patients with cystic fibrosis. Pediatrics1971;48:51–58.
13.
RoyCC, WeberAM, MorinCL, LePageG, BrissonG, YousefI, . Hepatobiliary disease in cystic fibrosis: A survey of current issues and concepts. J Pediatr Gastroenterol Nutr1982;1:469–478.
14.
OrensteinDM, HenkeKG, CostillDL, DoershukCF, LemonPJ, SternRC. Exercise and heat stress in cystic fibrosis patients. Pediatr Res1983;17:267–269.
15.
BeckermanRC, TaussigLM. Hypoelectrolytemia and metabolic alkalosis in infants with cystic fibrosis. Pediatrics1979;63:580–583.
16.
SternRC, BoatTF, WoodRE, MatthewsLW, DoershukCF. Treatment and prognosis of nasal polyps in cystic fibrosis. AJDC1982; 136:1067–1070.
17.
CoreyM, LevisonH, CrozierD.Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis1976;114:1085–1092.
18.
PattishallEN. Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis. Pediatr Pulmonol1990;9:80–85.
19.
ThomassenMJ, DemkoCA, DoershukCF. Cystic fibrosis: A review of pulmonary infections and interventions. Pediatr Pulmonol1987;3: 334–351.
20.
MarksMI. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr1981;98:173–179.
21.
WoodRE, WannerA, HirschJ, FarrellPM. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis1975;111:733–738.
22.
ThomassenMJ, BoxerbaumB, DemkoCA, KuchenbrodPJ, DearbornDG, WoodRE. Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages. Pediatr Res1979;13:1085–1088.
23.
TosiMF, ZakemH, BergerM.Neutrophil elastase cleaves c3bi on opsonized pseudomonas as well as CRI on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest1990;86:300–308.
24.
KaplanE, SchwachmanH, PerlmutterA, RuleA, KhawKT, HolsclawD.Reproductive failure in males with CF. N Engl J Med1968;279:65–69.
25.
KopitoLE, KosaskyHJ, SchwachmanH.Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertility Sterility1973;24:512–516.
26.
OrensteinDM. Diagnosis of cystic fibrosis. Semin Respir Med1985; 6:252–260.
WoodRE, BoatTF, DoershukCF. State of the art: Cystic fibrosis. Am Rev Respir Dis1976;113:833–878.
29.
WilckenB, BrownARD, UrwinR, BrownDA. Cystic fibrosis screening by dried spot trypsin assay: Results in 75,000 newborn infants. J Pediatr1983;102:383–387.
30.
OrensteinDM, BoatTF, SternRC, TuckerAS, CharnockEL. The effect of early diagnosis and treatment in cystic fibrosis: A seven year study of 16 sibling pairs. AJDC1977;131:973–975.
31.
ReismanJJ, Rivington-LawB, CoreyM, MarcotteJ, WannamakerE, HarcourtD, . Role of conventional physiotherapy in cystic fibrosis. J Pediatr1988;113:632–636.
32.
OrensteinDM, FranklinBA, DoershukCF, HellersteinHK, GermannKJ, HorowitzJG, . Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest1981;80:392–398.
33.
OrensteinDM, HenkeKG, CernyFJ. Exercise and cystic fibrosis. Physician Sports Med1983;11:57–62.
34.
LandauLI, PhelanPD. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr1973;82:863–868.
35.
ScanlinTF. Cystic fibrosis. In: FishmanAP, editor. Pulmonary diseases and disorders, 2nd ed. New York: McGraw Hill Book Co, 1998:1273–1294.
36.
KnowlesMR, ChurchNL, WaltnerWE, YanaskasJR, GilliganP, KingM, . A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med1990;322:1189–1194.
37.
AitkenML, BurkeW, McDonaldG, VillalonM, ShakS, MontgomeryAB, . Effect of inhaled recombinant human DNase on pulmonary function in normal and cystic fibrosis patients: Phase 1 study (abstract). Am Rev Respir Dis1991;143:A298.
AuerbachHS, WilliamM, KirkpatrickJA, ColtenHR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet1985;2:686–688.
40.
KonstanMW, VargoKM, DavisPB. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in arat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. Am Rev Respir Dis1990;141:186–192.
41.
RosensteinBJ, EigenH.Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics1991;87:245–246.
42.
GrenierB.Use of the new quinolones in cystic fibrosis. Rev Infect Dis1989;11(suppl 5):S1245–S1251.
McLaughlinRJ, MatthewsWJ, StreiderDJ, KhawDT, SchusterS, ShwachmanH.Pneumothorax in cystic fibrosis: Management and outcome. J Pediatr1982;100:863–869.
45.
SpectorML, SternRC. Pneumothorax in cystic fibrosis: A 26-year experience. Ann Thorac Surg1989;47:204–207.
46.
SternRC, WoodRE, BoatTF, MatthewsLW, TuckerAS, DoershukCF. Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev Respir Dis1978;117:825–828.
47.
HolsclawDS, GrandRJ, ShwachmanH.Massive hemoptysis in cystic fibrosis. J Pediatr1970;76:829–838.
48.
FellowsKE, KhawKT, SchusterS, ShwachmanH.Bronchial artery embolization in cystic fibrosis: Technique and long-term results. J Pediatr1979;95:959–963.
49.
KoletzkoS, StringerDA, CleghornGJ, DuriePR. Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis. Pediatrics1989;83:727–733.
50.
PsacharopoulosHT, HowardER, PortmannB, MowatAP, WilliamsR.Hepatic complications of cystic fibrosis. Lancet1981;278–280.
Cystic Fibrosis Foundation Data Registry Report for 1989. Bethesda MD: Cystic Fibrosis Foundation, 1990.
55.
MacLuskyI, McLaughlinFJ, LevisonH.Cystic fibrosis. Part II. Curr Probl Pediatr1985;15:1–39.
56.
SternRC, BoatTF, DoershukCF, TuckerAS, PrimianoFPJr, MatthewsLW. Course of cystic fibrosis in 95 patients. J Pediatr1976;89:406–411.
57.
DrummML, PopeHA, CliffWH, RommensJM, MarvinSA, TsuiL-C, . Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell1990;62:1227–1233.